Open AccessBloodstream Infections Caused by Magnusiomyces capitatus and Magnusiomyces clavatus : Epidemiological, Clinical, and Microbiological Features of Two Emerging Yeast Species
Author(s) -
Janioster,
M. M. van de Koppel,
Marie DesnosOllivier,
Maria Aigner,
Oliver Bader,
Karl Dichtl,
Stephan Göttig,
A. R. C. Haas,
Oliver Kurzai,
Arthur B. Pranada,
Yvonne Stelzer,
Grit Walther,
Axel Hamprecht
Publication year - 2022
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01834-21
Subject(s) - broth microdilution , voriconazole , microbiology and biotechnology , biology , posaconazole , amphotericin b , micafungin , antifungal , minimum inhibitory concentration , antimicrobial
Magnusiomyces clavatus andMagnusiomyces capitatus are emerging yeasts with intrinsic resistance to many commonly used antifungal agents. Identification is difficult, and determination of susceptibility patterns with commercial and reference methods is equally challenging. For this reason, few data on invasive infections byMagnusiomyces spp. are available.